In our study, the FNDC3B high-expression group displayed higher values for immune, stromal, and ESTIMATE scores than the FNDC3B low-expression group, indicating that the high expression level of FNDC3B is positively related to immune infiltration in gliomas. This evidence concerns the gene FNDC3B and glioma.